Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam

Klebsiella pneumoniae with capsule type K64 is... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/10-454" }, "headline": "Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam", "datePublished": "2021-06-08T11:35:10", "dateModified": "2025-01-17T17:10:23", "author": [ { "@type": "Person", "name": "Bich Vu Thi Ngoc" }, { "@type": "Person", "name": "Sylvain Brisse" }, { "@type": "Person", "name": "Trinh Dao Tuyet" }, { "@type": "Person", "name": "Dung Vu Tien Viet" }, { "@type": "Person", "name": "Kathryn E Holt" }, { "@type": "Person", "name": "Trung Nguyen Vu" }, { "@type": "Person", "name": "Huong Tran Thi Kieu" }, { "@type": "Person", "name": "Diep Nguyen Thi Ngoc" }, { "@type": "Person", "name": "H Rogier van Doorn" }, { "@type": "Person", "name": "Heiman F L Wertheim" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": " Introduction Recent reports indicate the emergence of community-acquired pneumonia associated with K64- Klebsiella pneumoniae (K. pneumoniae). Here, we identify the capsular types and sequence type of invasive and commensal K. pneumoniae isolates from Vietnam. Methods We included 93 K. pneumoniae isolates from patients hospitalized at the National Hospital for Tropical Diseases, Hanoi between 2007 and 2011; and 110 commensal isolates from throat swabs from healthy volunteers living in rural and urban Hanoi in 2012. We determined sequence types (STs) by multi-locus sequence typing (MLST) and capsule typing for seven K types by PCR. Antibiotic susceptibility testing was performed using disk diffusion. Results The most common detected capsule types were K1 (39/203, 19.2%, mainly ST23) and K2 (31/203, 15.3%, multiple STs: ST65, ST86, ST380). We found significantly more K2 isolates among invasive in comparison to commensal isolates (22.6% vs 9%, p = 0.01) but no significant difference was observed between invasive and commensal K1 isolates (14.5% vs 24.7%, p = 0.075). K64 with varying sequence types were predominantly seen among invasive K. pneumoniae (8 vs. 3) and were isolated from sepsis and meningitis patients. Among K64 isolates, one was carbapenem-resistant with ST799. Conclusion Our study confirms that capsule type K64 K. pneumoniae is associated with community-acquired invasive infections in Vietnam. Research is needed to unravel the mechanisms of virulence of capsule type K64 in both community and hospital settings. " } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/10-454/v2", "name": "Klebsiella pneumoniae with capsule type K64 is overrepresented among..." } } ] } Home Browse Klebsiella pneumoniae with capsule type K64 is overrepresented among... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Vu Thi Ngoc B, Brisse S, Dao Tuyet T et al. Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.12688/f1000research.52799.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Brief Report Revised Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] Bich Vu Thi Ngoc https://orcid.org/0000-0001-6870-4096 1 , Sylvain Brisse 2-4 , Trinh Dao Tuyet 5 , [...] Dung Vu Tien Viet 1 , Kathryn E Holt 6 , Trung Nguyen Vu 5 , Huong Tran Thi Kieu 1 , Diep Nguyen Thi Ngoc 1 , H Rogier van Doorn https://orcid.org/0000-0002-9807-1821 1,7 , Heiman F L Wertheim 1,8 Bich Vu Thi Ngoc https://orcid.org/0000-0001-6870-4096 1 , Sylvain Brisse 2-4 , [...] Trinh Dao Tuyet 5 , Dung Vu Tien Viet 1 , Kathryn E Holt 6 , Trung Nguyen Vu 5 , Huong Tran Thi Kieu 1 , Diep Nguyen Thi Ngoc 1 , H Rogier van Doorn https://orcid.org/0000-0002-9807-1821 1,7 , Heiman F L Wertheim 1,8 PUBLISHED 17 Jan 2025 Author details Author details 1 Oxford University Clinical Research Unit - Hanoi, Hanoi, Vietnam 2 French National Centre for Scientific Research, Paris, France 3 Microbial Evolutionary Genomics, Institut Pasteur, Microbial Evolutionary Genomics, Paris, France, Paris, France 4 Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, F-75015, Paris, France 5 National Hospital of Tropical Diseases, Hanoi, Vietnam 6 Department of Biochemistry & Molecular Biology, Centre for Systems Genomics, University of Melbourne, Melbourne, Australia 7 Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK 8 Department of Medical Microbiology and Radboudumc Center for Infectious Diseases, Radboudumc, Nijmegen, The Netherlands Bich Vu Thi Ngoc Roles: Data Curation, Methodology, Writing – Original Draft Preparation Sylvain Brisse Roles: Conceptualization, Writing – Review & Editing Trinh Dao Tuyet Roles: Methodology, Resources Dung Vu Tien Viet Roles: Formal Analysis Kathryn E Holt Roles: Conceptualization Trung Nguyen Vu Roles: Methodology Huong Tran Thi Kieu Roles: Methodology Diep Nguyen Thi Ngoc Roles: Methodology H Rogier van Doorn Roles: Supervision, Writing – Review & Editing Heiman F L Wertheim Roles: Conceptualization, Supervision, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS This article is included in the Pathogens gateway. Abstract Introduction Recent reports indicate the emergence of community-acquired pneumonia associated with K64- Klebsiella pneumoniae (K. pneumoniae) . Here, we identify the capsular types and sequence type of invasive and commensal K. pneumoniae isolates from Vietnam. Methods We included 93 K. pneumoniae isolates from patients hospitalized at the National Hospital for Tropical Diseases, Hanoi between 2007 and 2011; and 110 commensal isolates from throat swabs from healthy volunteers living in rural and urban Hanoi in 2012. We determined sequence types (STs) by multi-locus sequence typing (MLST) and capsule typing for seven K types by PCR. Antibiotic susceptibility testing was performed using disk diffusion. Results The most common detected capsule types were K1 (39/203, 19.2%, mainly ST23) and K2 (31/203, 15.3%, multiple STs: ST65, ST86, ST380). We found significantly more K2 isolates among invasive in comparison to commensal isolates (22.6% vs 9%, p = 0.01) but no significant difference was observed between invasive and commensal K1 isolates (14.5% vs 24.7%, p = 0.075). K64 with varying sequence types were predominantly seen among invasive K. pneumoniae (8 vs. 3) and were isolated from sepsis and meningitis patients. Among K64 isolates, one was carbapenem-resistant with ST799. Conclusion Our study confirms that capsule type K64 K. pneumoniae is associated with community-acquired invasive infections in Vietnam. Research is needed to unravel the mechanisms of virulence of capsule type K64 in both community and hospital settings. READ ALL READ LESS Keywords Klebsiella pneumoniae, K64, capsule type, community-acquired infections, carbapenem-resistant Corresponding Author(s) Bich Vu Thi Ngoc ( [email protected] ) Close Corresponding author: Bich Vu Thi Ngoc Competing interests: No competing interests were disclosed. Grant information: Wellcome Trust OxTREC, 49-12 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2025 Vu Thi Ngoc B et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Vu Thi Ngoc B, Brisse S, Dao Tuyet T et al. Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.12688/f1000research.52799.2 ) First published: 08 Jun 2021, 10 :454 ( https://doi.org/10.12688/f1000research.52799.1 ) Latest published: 17 Jan 2025, 10 :454 ( https://doi.org/10.12688/f1000research.52799.2 ) Revised Amendments from Version 1 The major differences between the old and new versions include updates based on recent understanding of K. pneumoniae and the K64 type, as well as revisions made in response to reviewer feedback. The methods section has been clarified, particularly regarding antibiotic susceptibility and the statistical methods applied in the analysis. Additionally, Table 1 has been revised to correct a typo that led to bias in the selection of one strain for the study. In the discussion, we address the study's limitations and further suggest the role of the K64 type in K. pneumoniae pathogenicity. The major differences between the old and new versions include updates based on recent understanding of K. pneumoniae and the K64 type, as well as revisions made in response to reviewer feedback. The methods section has been clarified, particularly regarding antibiotic susceptibility and the statistical methods applied in the analysis. Additionally, Table 1 has been revised to correct a typo that led to bias in the selection of one strain for the study. In the discussion, we address the study's limitations and further suggest the role of the K64 type in K. pneumoniae pathogenicity. See the authors' detailed response to the review by John L. Kiley READ REVIEWER RESPONSES Introduction In low and middle-income countries in Asia, like Vietnam, K. pneumoniae is an important cause of severe community-acquired infections, including pneumonia, liver abscesses and sepsis. 1 Multidrug-resistance in K. pneumoniae , especially among hospital acquired infections, is an emerging problem associated with high morbidity and mortality. 2 K. pneumoniae is classified across two main virulence phenotypes, classical (cKp) and hypervirulent (hvKp). Most K. pneumoniae are associated with uncomplicated community acquired infections and nocosomial infections. However, hvKp results in more severe community – acquired infections with manifestations such as pyogenic liver abscess, meningitis, endophthalmitis, and necrotizing fasciitis. 3 The polysaccharide capsule is perhaps the most well-known virulence factor of K. pneumoniae, including for the hvKp phenotype. The capsule surrounding K. pneumoniae cells can be divided into at least 79 capsular types (K1 to K79), among which K1, K2, and K64 are common serotypes of the MDR-hvKp group, which is commonly found in Asia. 4 , 5 A genomic analysis of diversity and population structure of 288 human and animal K. pneumoniae isolates from six countries, spanning four continents, has shown that K64 was among the important capsule types associated with community acquired pneumonia in Vietnam (n = 3) and Singapore (n = 1). 5 In addition to cases and outbreaks reported on severe K. pneumoniae infections by K64 capsular type with the convergence of carbapenem-resistant phenotypes, 6 in one case report, K64-ST1764 K. pneumoniae was found to be a cause of pyogenic liver abscess and endogenous endophthalmitis. K. pneumoniae can asymptomatically colonize the gastrointestinal (proportion between 40% to 66%) 7 and upper respiratory tract of healthy humans (14.1%) 8 but carriage of K64 K. pneumoniae in healthy persons has rarely been described. According to previous studies, K1 and K2 are known to be highly virulent capsule types associated with community-acquired and hospital-acquired infections. K54 and K57 are mainly found in the human microbiome, particularly in the upper respiratory tract of healthy individuals. Our literature review indicates that K5 and K20 have been sporadically reported as pathogens, although they are less common. As for K64, reported by K. Holt et al. in 2015, it appears to be an emerging cause of severe disease. 5 , 9 Our study aims to investigate the diversity of K. pneumoniae in both community and hospital settings by classifying the diversity of capsular types. Here, we found K64- K. pneumoniae to be more common among invasive isolates as compared to commensal isolates isolated from Vietnamese individuals. Methods Klebsiella pneumoniae isolates and antibiotic susceptibility testing From a total of 589 K. pneumoniae that were isolated from patients hospitalized at the National Hospital of Tropical Diseases between 2007 and 2011, 332 isolates were recovered after re-cultivation. Of those, 30 isolates with lacking clinical metadata were excluded, leaving the remaining 302 isolates for downstream analysis. Ninety-three were isolated from otherwise sterile sites, including blood (n = 70), cerebrospinal fluid (CSF) (n = 7), and pus (n = 16). These were re-cultured and re-confirmed using biochemical test strips (API 20E, Biomérieux, Marcy l’Étoile, France). Antibiotic susceptibility testing (AST) using disk diffusion was done according to Clinical and Laboratory Standards Institute (CLSI) guidelines 2019. A phenotypic confirmatory double-disk test was performed for confirmation of ESBL production using CTX (30 mg) and CAZ (30 mg) disks alone and in combination with CA (10 mg) (Mast Diagnostic a GmbH, Reinfeld, Germany). We collected clinical data from patients infected with these isolates (invasive isolates) and classified their infections based on the definition of healthcare-associated and community-associated infections ( https://arpsp.cdc.gov/profile/infections?tab=nhsn ). To ensure that the isolates were from community-acquired infections, we used a time difference of ≥48 hours between the time of admission and the time of specimen collection. To compare invasive with commensal isolates, we used randomization tools ( https://www.randomizer.org/ ) to select 110 of 331 K. pneumoniae isolates from throat swabs of healthy volunteers living in rural (Bavi) and urban (DongDa district), Hanoi in 2012. The epidemiology of these healthy volunteers has been described in our previous study which was designed to investigate K. pneumoniae oropharyngeal carriage and rick factors in Vietnam. 8 Commensal isolates were tested and analysed in the same manner as invasive isolates. Molecular typing Invasive and commensal isolates were tested to identify their capsule types (for capsule types K1, K2, K5, K20, K54, K57, and K64) by polymerase chain reaction (PCR) according to previously described methods. 10 , 11 A specific K64 PCR was developed to detect capsule type K64 that was reported to be common in Southeast Asia 5 with the following primers: Forward (5′TTC TTT AAG TCT TCT GGG TAT CA3′) and Reverse (5′AGT CTT TAA TCG CCT TCT3′). The PCR cycling program for K64 consisted of 95°C for 15 min, followed by 30 cycles of 95 °C for 30 sec, 60 °C for 30 sec, 72 °C for 1 min 20 sec and the final elongation step was performed for 7 min at 72 °C. The PCR products were loaded on agarose (1.5%) gel electrophoresis. Samples contained PCR products with size equivalent to 782 bp as K64 positive. Multi-locus sequence typing (MLST) was performed by sequencing the PCR products of seven house-keeping genes including (gapA, infB, mdh, pgi, phoE, rpoB, tonB). The sequence of these genes was analysed using the BIGSdb-Pasteur website ( https://bigsdb.pasteur.fr/ ) for determining the sequence types. Sequence types (STs) were grouped into clonal complexes (CC) as described previously. 12 A clonal complex is defined as a group of STs with at least 6 identical alleles with at least one other member of the group. STs that did not fall within a CC were defined as singletons. We used Statistical Package of Social Sciences (SPSS) version 25 (IBM corporation, Armonk (NY), USA) for analysis, 13 p values < 0.05 were considered significant (2-sided). Ethics statement This study was approved by the Oxford University Tropical Research Ethics Committee (Oxtrec, 49-12) and the National Hospital for Tropical Diseases Institutional Review Board. Before participation, written informed consent from subjects or, in case of minors, their caregivers, was obtained on a standard study consent form. Results Among 203 K. pneumoniae isolates, 100 (49.2%) were positive with one of the seven tested capsule (K) types (K1, K2, K5, K20, K54, K57, K64). The most common K types were K1 (n = 39) and K2 (n = 31). Whereas 36/39 (92.3%) K1 isolates belonged to STs that were classified into clonal complex, CC23, K2 isolates were more diverse: the most frequent clonal complex was CC65 (n = 18), followed by CC86 (n = 8) ( Table 1 ). While K2 isolates were more prevalent among invasive than among commensal isolates (22.6% vs 9%, Chi-square, p = 0.01), K1 was relatively equally distributed (14.5% vs 24.7%, p = 0.075), and K57 (n = 18) was detected mostly among commensal isolates (15.4% vs 1%, p < 0.0001). We detected seven isolates with K64, five of which were invasive (p < 0.001). Among five invasive K64 K. pneumoniae , two were isolated from sepsis patients, one from meningitis, one from sepsis-meningitis, and one from the blood of a patient with hospital-acquired pneumonia. Most of these invasive K64 isolates (4/5) were from patients on Intensive Care Units (ICU). Of those patients, two had fatal community acquired pneumonia. The seven K64 isolates (two from commensal, five from invasive isolates) were genotyped by MLST: four belonged to the CC231 (ST231, ST799, ST807) and the other to CC65 (ST692). Table 1. Clonal complex (CCs) as determined by multi-locus sequence typing (MLST) and distribution of capsular types among invasive isolates and commensal isolates of Klebsiella pneumoniae in Vietnam. P-value were determined by Chi-square (2-sides) test. Clonal Complex (CC) Overall Commensal (n, %) Invasive (n, %) p-value 23 63 (31) 35 (31.8) 28 (28) 0.791 65 23 (11.3) 6 (5.5) 17 (18.2) 0.004 231 4 (2) 0 (0) 4 (4.3) 412 9 (4.4) 8 (7.3) 1 (1) 806 6 (3) 1 (1) 5 (5.3) 86 8 (4) 3 (2.7) 5 (5.3) Others CCs 23 (11.3) 15 (13.6) 7 (7.5) 0.251 Singleton 68 (34) 42 (38.1) 26 (27.9) 0.083 Capsular type K1 39 (19.2) 16 (14.5) 23 (24.7) 0.075 K2 31 (15.3) 10 (9) 21 (22.6) 0.01 K5 1 (0.5) 0 (0) 1 (1) 0.458 K20 2 (1) 2 (1.8) 0 (0) 0.5 K54 2 (1) 1 (1) 1 (1) 1 K57 18 (9) 17 (15.4) 1 (1) <0.0001 K64 7 (3.4) 2 (1.8) 5 (5.4) <0.0001 Overall, antimicrobial resistant proportions of commensal isolates differed significantly from invasive K. pneumoniae ( Table 2 ). Among K64 isolates, one invasive ST799 isolate from a patient with hospital-acquired pneumonia was multi-drug resistant, with resistance to imipenem, ciprofloxacin, trimethoprim/sulfamethoxazole, piperacillin-tazobactam and gentamicin. Of the remaining K64 isolates, four invasive isolates were non-carbapenem resistant but they either were resistant to trimethoprim/sulfamethoxazole or piperacillin-tazobactam. Whilst, the two commensal isolates with ST1331 and ST1347, were susceptible to all tested antibiotics. 14 Table 2. Comparison of the proportion of antibiotic resistance between invasive versus commensal Klebsiella pneumoniae isolates in Vietnam. P-value were determined by Chi-square (2-sides) test. Overall Commensal (n, %) Invasive (n, %) p-value ESBL 15 (7.4) 4 (3.6) 11 (11.8) 0.025 CIP (Ciprofloxacin) 7 (3.4) 0 (0) 7 (7.5) 0.002 AMC (Amoxicillin - clavulanate) 16 (7.8) 0 (0) 16 (17.2) 0.004 AMP (Ampicillin) 196 (96.5) 104 (94.5) 92 (98.5) 0.339 FEP (Cefepime) 9 (4.4) 0 (0) 9 (9.6) 0.001 GEN (Gentamicin) N/A N/A 14 (15) N/A TZP (Piperacillin -tazobactam) 6 (2.9) 0 (0) 6 (6.5) 0.008 SXT (Trimethoprim-sulfamethoxazole) 29 (14.3) 9 (8.1) 20 (21.5) <0.001 IMP (Imipenem) 1 (0.5) 0 (0) 1 (1) 0.458 Discussion and conclusion In addition to the emergence of carbapenem-resistant K. pneumoniae worldwide, previous studies have shown that infections caused by hypervirulent carbapenem susceptible K. pneumoniae can also be considered a threat to public health. 15 Our study suggested that besides capsule type K2, capsule type K64 was associated with invasive strains (5.4% vs 1.8%, Chi-square, p < 0.001), consistent with previous studies. 5 , 16 The capsular type K64 has been reported worldwide, especially from clinical settings in Asia, Europe, and North America and is one of the K types associated with hypervirulent strains, that have shown simultaneous expression of virulence and carbapenem-resistance genes, posing a treatment challenge. 17 ST11-K64 is a common type in China, possibly leading to pyogenic liver abscesses. 9 Contrarily, our K64 strains were mainly found in sepsis and meningitis patients with varying STs, including: ST231, ST692, ST799, and ST807. Moreover, it is worth noting that K64 has been common in Klebsiella pneumoniae carbapenemase (KPC) producing ST11 strains in China, and the shift from K47 to K64 has been associated with increased virulence in this strain. 18 In our study, the carbapenem-resistant K64-ST799 was isolated from the blood of a hospital-acquired patient in 2011, and was not detected in subsequent years in surveillance efforts. 19 Likely, the K64-ST799 strain might have acquired a mobile element carrying a carbapenemase-producing gene. In particular, K64 has been recently recognized as a capsular type potentially associated with hypervirulence and invasive disease. Indeed, the presence of K64 with several STs isolated from bacteraemia and meningitis patients in Vietnam and a pyogenic liver abscess patient in China 20 provides further evidence that strains with this capsule type are virulent. 21 The present study has several limitations. Because of the retrospective nature of the analyzed data collection, we missed some clinical data (exposures, alcohol history, out come after treatment) of the patients. The results of this study lack evidence to support the hypothesis that the risk factor of infections may be K. pneumoniae colonizers. In this study, the relatively small number of K64 isolates provided only limited data about the serotype's convergent virulence and carbapenem resistance. Also, we lack the whole genome sequence data of these K64 isolates for further understanding the molecular basis of hypervirulence and the phylogenetic positioning of this rare ST within the genomic taxonomy of K. pneumoniae . 22 However, our results led support to the hypothesis that K64 is associated with severe invasive community acquired K. pneumoniae infections, including sepsis and meningitis. In addition, here, only seven capsule types were selected to investigate the diversity of K. pneumoniae isolates. We recognize that this is one of the limitations of our study. Further studies are needed to unravel the mechanisms of virulence of capsule type K64 in K. pneumoniae. Data availability Underlying data Dryad: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam. https://doi.org/10.5061/dryad.h44j0zpjv 14 • Table 1 (Kp_All_AST) provides the detailed information of 203 Klebsiella pneumoniae isolates including source of isolates, date of collection, antibiotic susceptibility profiles, K-serotypes and MLST profiles. • Serotype_Clinical isolates.rar and Serotype_Community isolates.rar: These folders contain the photographs of the PCR products of agarose gel electrophoresis. Maps of samples on agarose plates are described in two Excel files (Electrophoresis_map.xlsx and Isolate ID on Electrophoresis.gel.xlsx for Clinical isolates and Commensal isolates, respectively). Data are available under the terms of the Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Public domain dedication). Consent Before participation, written informed consent from subjects or, in case of minors, their caregivers, was obtained on a standard study consent form. References 1. Peto L, Nadjm B, Horby P, et al. : The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014 Jun; 108 (6): 326–37. PubMed Abstract | Publisher Full Text | Free Full Text 2. Cillóniz C, Dominedò C, Torres A: Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia. Crit Care. 2019; 23 (1): 79. PubMed Abstract | Publisher Full Text | Free Full Text 3. Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H: Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes? Virulence. 2017; 8 (7): 1111–23. PubMed Abstract | Publisher Full Text | Free Full Text 4. Zhu J, Wang T, Chen L, et al. : Virulence Factors in Hypervirulent Klebsiella pneumoniae. Front Microbiol. 2021; 12 : 642484. [published Online First: 2021/04/27] PubMed Abstract | Publisher Full Text | Free Full Text 5. Holt KE, Wertheim H, Zadoks RN, et al. : Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A. 2015; 112 (27): E3574–E81. PubMed Abstract | Publisher Full Text | Free Full Text 6. Zhang X, Ouyang J, He W, et al. : Co-occurrence of Rapid Gene Gain and Loss in an Interhospital Outbreak of Carbapenem-Resistant Hypervirulent ST11-K64 Klebsiella pneumoniae. Front Microbiol. 2020; 11 : 579618. PubMed Abstract | Publisher Full Text | Free Full Text 7. Huynh BT, Passet V, Rakotondrasoa A, et al. : Klebsiella pneumoniae carriage in low-income countries: antimicrobial resistance, genomic diversity and risk factors.2020 Sep 2; 11 (5): 1287–99. PubMed Abstract | Publisher Full Text | Free Full Text 8. Dao TT, Liebenthal D, Tran TK, et al. : Klebsiella pneumoniae Oropharyngeal Carriage in Rural and Urban Vietnam and the Effect of Alcohol Consumption. PloS one. 2014; 9 (3): e91999. PubMed Abstract | Publisher Full Text | Free Full Text 9. Zhang Y, Jin L, Ouyang P, et al. : Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother. 2020 Feb 1; 75 (2): 327–36. PubMed Abstract | Publisher Full Text 10. Yeh KM, Lin JC, Yin FY, et al. : Revisiting the importance of virulence determinant magA and its surrounding genes in Klebsiella pneumoniae causing pyogenic liver abscesses: exact role in serotype K1 capsule formation. J Infect Dis. 2010 Apr 15; 201 (8): 1259–67. PubMed Abstract | Publisher Full Text 11. Pan Y-J, Lin T-L, Chen Y-H, et al. : Capsular Types of Klebsiella pneumoniae Revisited by wzc Sequencing. PloS one. 2013; 8 (12): e80670. PubMed Abstract | Publisher Full Text | Free Full Text 12. Diancourt L, Passet V, Verhoef J, et al. : Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates. J Clin Microbiol. 2005; 43 (8): 4178–82. PubMed Abstract | Publisher Full Text | Free Full Text 13. IBM SPSS Statistics for Windows: Version 25.0. ed.Armonk, NY: IBM Corp; 2017. 14. Bich VTN: Supplementary of: “ Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam.” DRYAD Dataset. 2021. Publisher Full Text 15. Choby JE, Howard-Anderson J, Weiss DS: Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives.2020 Mar; 287 (3): 283–300. PubMed Abstract | Publisher Full Text | Free Full Text 16. Yeh K-M, Kurup A, Siu LK, et al. : Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol. 2007 2007/02//; 45 (2): 466–71. PubMed Abstract | Publisher Full Text | Free Full Text 17. Yang Q, Jia X, Zhou M, et al. : Emergence of ST11-K47 and ST11-K64 hypervirulent carbapenem-resistant Klebsiella pneumoniae in bacterial liver abscesses from China: a molecular, biological, and epidemiological study. Emerg Microbes Infect. 2020; 9 (1): 320–31. PubMed Abstract | Publisher Full Text | Free Full Text 18. Zhou K, Xiao T, David S, et al. : Novel Subclone of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 with Enhanced Virulence and Transmissibility, China. Emerg Infect Dis. 2020 Feb; 26 (2): 289–97. PubMed Abstract | Publisher Full Text | Free Full Text 19. Wyres KL, Nguyen TNT, Lam MMC, et al. : Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Med. 2020 2020/01/16; 12 (1): 11. PubMed Abstract | Publisher Full Text | Free Full Text 20. Zhao B, Hu R, Gong L, et al. : Pyogenic Liver Abscess and Endogenous Endophthalmitis Due to K64-ST1764 Hypervirulent Klebsiella pneumoniae: A Case Report. Infect Drug Resist. 2021; 14 : 71–7. PubMed Abstract | Publisher Full Text | Free Full Text 21. Marr CM, Russo TA: Hypervirulent Klebsiella pneumoniae: a new public health threat. Expert Rev Anti Infect Ther. 2019 Feb; 17 (2): 71–3. PubMed Abstract | Publisher Full Text | Free Full Text 22. Palma F, Hennart M, Jolley KA, et al. : Bacterial strain nomenclature in the genomic era: Life Identification Numbers using a gene-by-gene approach. bioRxiv. 2024: 2024.03.11.584534. Publisher Full Text Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 08 Jun 2021 ADD YOUR COMMENT Comment Author details Author details 1 Oxford University Clinical Research Unit - Hanoi, Hanoi, Vietnam 2 French National Centre for Scientific Research, Paris, France 3 Microbial Evolutionary Genomics, Institut Pasteur, Microbial Evolutionary Genomics, Paris, France, Paris, France 4 Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, F-75015, Paris, France 5 National Hospital of Tropical Diseases, Hanoi, Vietnam 6 Department of Biochemistry & Molecular Biology, Centre for Systems Genomics, University of Melbourne, Melbourne, Australia 7 Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK 8 Department of Medical Microbiology and Radboudumc Center for Infectious Diseases, Radboudumc, Nijmegen, The Netherlands Bich Vu Thi Ngoc Roles: Data Curation, Methodology, Writing – Original Draft Preparation Sylvain Brisse Roles: Conceptualization, Writing – Review & Editing Trinh Dao Tuyet Roles: Methodology, Resources Dung Vu Tien Viet Roles: Formal Analysis Kathryn E Holt Roles: Conceptualization Trung Nguyen Vu Roles: Methodology Huong Tran Thi Kieu Roles: Methodology Diep Nguyen Thi Ngoc Roles: Methodology H Rogier van Doorn Roles: Supervision, Writing – Review & Editing Heiman F L Wertheim Roles: Conceptualization, Supervision, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information Wellcome Trust OxTREC, 49-12 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Article Versions (2) version 2 Revised Published: 17 Jan 2025, 10:454 https://doi.org/10.12688/f1000research.52799.2 version 1 Published: 08 Jun 2021, 10:454 https://doi.org/10.12688/f1000research.52799.1 Copyright © 2025 Vu Thi Ngoc B et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Vu Thi Ngoc B, Brisse S, Dao Tuyet T et al. Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.12688/f1000research.52799.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 2 VERSION 2 PUBLISHED 17 Jan 2025 Revised Views 0 Cite How to cite this report: García-González N. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r393103 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-393103 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 09 Aug 2025 Neris García-González , Instituto de Biomedicina de Valencia (Ringgold ID: 54426), Valencia, Valencian Community, Spain Approved with Reservations VIEWS 0 https://doi.org/10.5256/f1000research.176630.r393103 Peer Review for “ Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2]” The manuscript explores the distribution of Klebsiella pneumoniae capsule types, with a focus on K64, among invasive and commensal isolates in ... Continue reading READ ALL Peer Review for “ Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2]” The manuscript explores the distribution of Klebsiella pneumoniae capsule types, with a focus on K64, among invasive and commensal isolates in Vietnam. While the topic is relevant and the data valuable, I believe the conclusions are overstated given the limited number of K64 isolates. Several aspects of the methodology and analysis require clarification or revision, particularly to address the overstatement of key conclusions. Additionally, the overall writing—especially the methods section—would benefit from careful editing for clarity. Major Comments The conclusion that “Our study confirms that capsule type K64 K. pneumoniae is associated with community-acquired invasive infections in Vietnam” is, in my view, overstated given the data presented. Of the 100 isolates with a successfully determined capsular type, only 11 were K64 (5 from invasive, 2 from commensal samples). This is a very small number, and the application of statistical tests to such low counts does not support a definitive conclusion. Similarly, the claim that K64 is “associated with sepsis and meningitis” is unsupported. While some K64 isolates came from such cases, no analysis was done to test specific disease associations. This should be rephrased more cautiously (e.g., “were observed in”). The statement that “K64-ST799 might have acquired a mobile element carrying a carbapenemase gene” is speculative and not backed by molecular data. Without sequencing or resistance gene analysis, this claim should be softened. The authors tested for only seven capsule types (K1, K2, K5, K20, K54, K57, K64). It’s unclear why these were chosen—are they the most common in Vietnam, or just associated with hvKp globally? This should be clarified, especially since over half of the isolates were untypeable. Without knowing whether additional relevant types were missed, it is difficult to interpret the significance of the K64 frequency. The invasive isolates were collected between 2007–2011, while the commensal isolates were collected in 2012. The invasive and commensal isolates were collected in different time periods (2007–2011 vs. 2012), which could introduce temporal bias. This limitation should be acknowledged explicitly. The manuscript requires substantial revision for clarity. Several sentences are difficult to parse, and the structure of some sections hinders comprehension. For example: The methodology does not clearly explain how the 589 K. pneumoniae isolates were selected. Were these all from invasive infections? If so, and only 49.2% were typeable, a large proportion of relevant invasive capsule types may have been missed. Alternatively, if this set included both invasive and commensal isolates, it would improve the comparison by providing community data from the same time period. This should be clearly stated and clarified in the manuscript. The distinction between the two datasets (invasive and commensal) is clear in the abstract but not well explained in the main text. I suggest rephrasing to something similar to: “To compare invasive with commensal isolates, we included commensal isolates from a previous study. These were throat swabs from healthy volunteers in rural and urban Hanoi in 2012. …” The statement: “To ensure that the isolates were from community-acquired infections, we used a time difference of ≥48 hours…” is confusing. Community-acquired infections are typically defined as those occurring within 48 hours of hospital admission. This should be reworded for clarity. Minor Comments Define MDR (multidrug-resistant) on first mention. In Tables 1 and 2, “Overall” column should also have (n, %) Correct spelling of “nocosomial” to “nosocomial.” Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Partly Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Partly Are all the source data underlying the results available to ensure full reproducibility? No source data required Are the conclusions drawn adequately supported by the results? Partly Competing Interests: No competing interests were disclosed. Reviewer Expertise: microbial genomics I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT García-González N. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r393103 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-393103 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Dong N. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r383866 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-383866 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 06 Jun 2025 Ning Dong , Zhejiang University School of Medicine, Hangzhou, China Not Approved VIEWS 0 https://doi.org/10.5256/f1000research.176630.r383866 In this study on Klebsiella pneumoniae , the authors analyzed 203 clinical isolates and found that capsular K64 was significantly enriched in invasive infections, mainly associated with sepsis and meningitis, and some K64 strains (such as ST799) were multidrug resistant. ... Continue reading READ ALL In this study on Klebsiella pneumoniae , the authors analyzed 203 clinical isolates and found that capsular K64 was significantly enriched in invasive infections, mainly associated with sepsis and meningitis, and some K64 strains (such as ST799) were multidrug resistant. This study suggests that K64 is an important pathogen of community-acquired invasive infections in Vietnam. I suggest the following directions for further improvement of the study: The theoretical basis for capsule type selection was supplemented, and the latest literature (such as studies on the global prevalence of K64 after 2023) was cited to complete the discussion section. The sample size was small and underrepresented. The sample size of K64 strains was only 7 strains (5 invasive strains and 2 commensal strains), which was too small to support the conclusion that K64 was significantly enriched in invasive infections, which may lead to limited reliability of statistical results. Second, the commensal strains lack sample coverage from multiple regions and time points to fully reflect the epidemiological characteristics of community-acquired infections in Vietnam. The results "K64 with varying sequence types were predominantly seen among invasive K. pneumoniae (8 vs. 3)" was inconsistent with the table data in the text (5 invasive strains, 2 commensal strains). The whole genome sequencing data was supplemented to analyze the virulence genes (such as rmpA and magA ) and drug resistance genes (such as KPC and NDM ) of K64 strain, and to clarify its pathogenic mechanism at the molecular level. There is a logical jump between the conclusion and the data. The title and conclusion use the word "overrepresented", which is misleading. Because the proportion of K64 in invasive strains was only 5.4% (5/93), which was much lower than that of K1 (24.7%) and K2 (22.6%). Second, it was mentioned that K64 was associated with carbapenem resistance (such as the ST799 strain). However, the finding of only one drug-resistant strain cannot support the inference that the K64 strain is generally resistant to carbapenem, and more data are needed to verify it. Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Partly Competing Interests: No competing interests were disclosed. Reviewer Expertise: Epidemiology of infectious diseases I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Dong N. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r383866 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-383866 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: DeLeo FR. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r360165 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-360165 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 28 Jan 2025 Frank R. DeLeo , Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA Approved VIEWS 0 https://doi.org/10.5256/f1000research.176630.r360165 Revised version ... Continue reading READ ALL Revised version is appropriate. Competing Interests: No competing interests were disclosed. Reviewer Expertise: Bacterial pathogenesis and host defense. Primary focus on Staphylococcus aureus, Klebsiella pneumoniae, and human neutrophil biology. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT DeLeo FR. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r360165 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-360165 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Version 1 VERSION 1 PUBLISHED 08 Jun 2021 Views 0 Cite How to cite this report: DeLeo FR. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.56121.r287539 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v1#referee-response-287539 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 28 Jun 2024 Frank R. DeLeo , Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA Approved with Reservations VIEWS 0 https://doi.org/10.5256/f1000research.56121.r287539 Ngoc et al. report capsule type and multilocus sequence type of Klebsiella pneumoniae clinical isolates from patients hospitalized at National Hospital for Tropical Diseases in Hanoi from 2007 to 2011. The authors compared these isolates to commensal isolates obtained by ... Continue reading READ ALL Ngoc et al. report capsule type and multilocus sequence type of Klebsiella pneumoniae clinical isolates from patients hospitalized at National Hospital for Tropical Diseases in Hanoi from 2007 to 2011. The authors compared these isolates to commensal isolates obtained by throat swab from healthy volunteers in 2012. The study is interesting and adds to our understanding of the distribution of the K. pneumoniae capsule types associated with human infections. I have a few comments for the authors to consider. Please verify numbers of isolates in Table 1 compared with what is stated in the text. By my count, there are 110 commensal isolates (correct in the text) and 94 (stated as 93 in the text) invasive isolates. These numbers are concordant with the sum of the numbers in the Overall column, which total 204 isolates (the text indicates 203). Please verify for accuracy. It would be optimal to provide text in the Table 1 legend that states what the p-value refers to from a comparison standpoint, and indicate the test used here as well. I recommend providing the rationale for selecting the seven capsule types used to screen isolates in this study. Why were these seven capsule types chosen among others? A conclusion of the study is that “capsule type K64 is overrepresented among invasive strains”. In reality there are only seven K64 isolates out of 204 total isolates and only five of these were from invasive disease. This is 5.4% of the total number of invasive isolates and much less than either K1 or K2. In addition, the Conclusion text on the title page states that K64 K. pneumoniae is associated with community-acquired invasive infections in Vietnam.” Please provide the criteria in the Methods section that were used to determine whether an infection is a bona fide community-acquired infection. It would be fair to state that K64 contributes to invasive disease and is among the top three capsule types tested that are associated with invasive infections. However, the term “overrepresented among invasive strains” might best be restated as “there were significantly more capsule type K64 isolates recovered from patients with invasive infections compared to healthy individuals with commensal isolates” or something along those lines. Minor points. Introduction: “A genomic analysis of diversity and population structure of 288 human and animal K. pneumoniae isolates from six countries, spanning four continents, has shown that K64 mostly found in Vietnam (n = 3) and Singapore (n = 1), was among the important capsule types associated with community acquired pneumonia.” is not easy to read. Consider revising to: “A genomic analysis of diversity and population structure of 288 human and animal K. pneumoniae isolates from six countries, spanning four continents, has shown that K64 was among the important capsule types associated with community acquired pneumonia in Vietnam (n = 3) and Singapore (n = 1).” Introduction, penultimate sentence: change K64 capsular to K64 capsule types Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Partly If applicable, is the statistical analysis and its interpretation appropriate? I cannot comment. A qualified statistician is required. Are all the source data underlying the results available to ensure full reproducibility? Partly Are the conclusions drawn adequately supported by the results? Partly Competing Interests: No competing interests were disclosed. Reviewer Expertise: Bacterial pathogenesis and host defense. Primary focus on Staphylococcus aureus, Klebsiella pneumoniae, and human neutrophil biology. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT DeLeo FR. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.56121.r287539 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v1#referee-response-287539 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Kiley JL. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.56121.r93803 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v1#referee-response-93803 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 12 Oct 2021 John L. Kiley , Brooke Army Medical Center, San Antonio, TX, USA Approved with Reservations VIEWS 0 https://doi.org/10.5256/f1000research.56121.r93803 This paper describes the epidemiology of K64 Klebsiella pneumoniae isolates with a particular focus on K64 from a hospital in Vietnam. Introduction "...but K64 capsular have rarely been described in healthy carriers." in the introductory ... Continue reading READ ALL This paper describes the epidemiology of K64 Klebsiella pneumoniae isolates with a particular focus on K64 from a hospital in Vietnam. Introduction "...but K64 capsular have rarely been described in healthy carriers." in the introductory paragraph reads a bit unclearly. Adding a bit more about the importance of K64 and the differences between classic and hypervirulent types of Klebsiella spp. (as well as how capsules might play a role in this) would better situate the authors' opening argument as to why they are performing this current study. Methods "302 K. pneumoniae were isolated..." are these all isolates from the hospital during this time period? Results I note that ESBL production was determined in Table 2 - please clarify how you determined this in the methods. Discussion and conclusion I think some discussion about the small numbers of K64 isolates would also be helpful in the limitations of the paper. The second paragraph starts off by suggesting K64 has "been little reported so far," but I think the data from China would argue against this. Zhang et al ., 2020 reported Chinese epidemiological data on K64 1 . Walker et al ., 2020 for general discussion of hypervirulence and association with capsular type 2 . Catalán-Nájera et al ., 2017 for hypermucoviscious, hypervirulent differences/discussion 3 . Great paper overall! Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes References 1. Zhang Y, Jin L, Ouyang P, Wang Q, et al.: Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. Journal of Antimicrobial Chemotherapy . 2020; 75 (2): 327-336 Publisher Full Text 2. Walker KA, Miller VL: The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae. Curr Opin Microbiol . 54 : 95-102 PubMed Abstract | Publisher Full Text 3. Catalán-Nájera J, Garza-Ramos U, Barrios-Camacho H: Hypervirulence and hypermucoviscosity: Two different but complementaryKlebsiella spp. phenotypes?. Virulence . 2017; 8 (7): 1111-1123 Publisher Full Text Competing Interests: No competing interests were disclosed. Reviewer Expertise: Multi drug resistant Gram-negative infections I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Kiley JL. Reviewer Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.56121.r93803 ) The direct URL for this report is: https://f1000research.com/articles/10-454/v1#referee-response-93803 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 17 Jan 2025 Bich Vu Thi Ngoc , Oxford University Clinical Research Unit - Hanoi, Hanoi, Vietnam 17 Jan 2025 Author Response We would like to thank reviewer for your valuable comments. We have addressed all the reviewers’ comments in the revised manuscript, including with additional information, and responded in the point-to-point ... Continue reading We would like to thank reviewer for your valuable comments. We have addressed all the reviewers’ comments in the revised manuscript, including with additional information, and responded in the point-to-point rebuttal below. We hope our revisions are adequate and make our manuscript clear and publishable. Reviewer 1 This paper describes the epidemiology of K64 Klebsiella pneumoniae isolates with a particular focus on K64 from a hospital in Vietnam. Comment 1 : Introduction "...but K64 capsular have rarely been described in healthy carriers." in the introductory paragraph reads a bit unclearly. Response : Thank you very much for your comment. We have now revised the sentence in the updated version as below: “…but carriage of K64 K. pneumoniae in healthy persons has rarely been described.” Comment 2: Adding a bit more about the importance of K64 and the differences between classic and hypervirulent types of Klebsiella spp. (as well as how capsules might play a role in this) would better situate the authors' opening argument as to why they are performing this current study. Response: Thank you very much for your recommendation. We have now included the following sentences in the introduction of the manuscript: K pneumoniae is classified across two main virulence phenotypes, classical (cKp) and hypervirulent (hvKp). Most K. pneumoniae are associated with uncomplicated community acquired infections and nocosomial infections. However, hvKp results in more severe community – acquired infections with manifestations such as pyogenic liver abscess, meningitis, endophthalmitis, and necrotizing fasciitis. The polysaccharide capsule is perhaps the most well-known virulence factor of K. pneumoniae , including for the hvKp phenotype. The capsule surrounding K. pneumoniae cells can be divided into at least 79 capsular types (K1 to K79), among which K1, K2, and K64 are common serotypes of the MDR-hvKp group, which is commonly found in Asia. Comment 3: Methods "302 K. pneumoniae were isolated..." are these all isolates from the hospital during this time period? Response: Thank you very much for your question. The total number of isolates from the hospital during this time was 589 isolates; however, because this was a retrospective study, we performed re-culture, and 332/589 isolates were recovered. Of those, 30 isolates had no associated clinical metadata, and were excluded from the study. We now have clarified this in the manuscript as below: “From a total of 589 K. pneumoniae that were isolated from patients hospitalized at the National Hospital of Tropical Diseases between 2007 and 2011, 332 isolates were recovered after re-cultivation. Of those, 30 isolates with lacking clinical metadata were excluded, leaving the remaining 302 isolates for downstream analysis.” Comment 4: Results I note that ESBL production was determined in Table 2 - please clarify how you determined this in the methods. Response: Thank you very much for your comment. We have added the information into the updated version as below: “A phenotypic confirmatory double-disk test was performed for confirmation of ESBL production using CTX (30 mg) and CAZ (30 mg) disks alone and in combination with CA (10 mg) (Mast Diagnostic a GmbH, Reinfeld, Germany).” Comment 5: Discussion and conclusion I think some discussion about the small numbers of K64 isolates would also be helpful in the limitations of the paper. The second paragraph starts off by suggesting K64 has "been little reported so far," but I think the data from China would argue against this. Response: Thank you for your recommendation. We agree that data from China would argue against our statement in the second paragraph starts off by suggesting K64 has "been little reported so far,". We now have revised the sentence as below: “The capsular type K64 has been reported worldwide, especially from clinical settings in Asia, Europe, and North America and is one of the K types associated with hypervirulent strains, that have shown simultaneous expression of virulence and carbapenem-resistance genes, posing a treatment challenge.” Regarding the small numbers of K64 isolates in our study, we have added into the limitation: “In this study, the relatively small number of K64 isolates provided only limited data about the serotype's convergent virulence and carbapenem resistance. Also, we lack the whole genome sequence data of these K64 isolates for further understanding of the molecular basis of hypervirulence and the phylogenetic positioning of this rare ST within the genomic taxonomy of K. pneumoniae . However, our results led support to the hypothesis that K64 is associated with severe invasive community acquired K. pneumoniae infections, including sepsis and meningitis. In addition, here, only seven capsule types were selected to investigate the diversity of K. pneumoniae isolates. We recognize that this is one of the limitations of our study. Further studies are needed to unravel the mechanisms of virulence of capsule type K64 in K. pneumoniae .” We would like to thank reviewer for your valuable comments. We have addressed all the reviewers’ comments in the revised manuscript, including with additional information, and responded in the point-to-point rebuttal below. We hope our revisions are adequate and make our manuscript clear and publishable. Reviewer 1 This paper describes the epidemiology of K64 Klebsiella pneumoniae isolates with a particular focus on K64 from a hospital in Vietnam. Comment 1 : Introduction "...but K64 capsular have rarely been described in healthy carriers." in the introductory paragraph reads a bit unclearly. Response : Thank you very much for your comment. We have now revised the sentence in the updated version as below: “…but carriage of K64 K. pneumoniae in healthy persons has rarely been described.” Comment 2: Adding a bit more about the importance of K64 and the differences between classic and hypervirulent types of Klebsiella spp. (as well as how capsules might play a role in this) would better situate the authors' opening argument as to why they are performing this current study. Response: Thank you very much for your recommendation. We have now included the following sentences in the introduction of the manuscript: K pneumoniae is classified across two main virulence phenotypes, classical (cKp) and hypervirulent (hvKp). Most K. pneumoniae are associated with uncomplicated community acquired infections and nocosomial infections. However, hvKp results in more severe community – acquired infections with manifestations such as pyogenic liver abscess, meningitis, endophthalmitis, and necrotizing fasciitis. The polysaccharide capsule is perhaps the most well-known virulence factor of K. pneumoniae , including for the hvKp phenotype. The capsule surrounding K. pneumoniae cells can be divided into at least 79 capsular types (K1 to K79), among which K1, K2, and K64 are common serotypes of the MDR-hvKp group, which is commonly found in Asia. Comment 3: Methods "302 K. pneumoniae were isolated..." are these all isolates from the hospital during this time period? Response: Thank you very much for your question. The total number of isolates from the hospital during this time was 589 isolates; however, because this was a retrospective study, we performed re-culture, and 332/589 isolates were recovered. Of those, 30 isolates had no associated clinical metadata, and were excluded from the study. We now have clarified this in the manuscript as below: “From a total of 589 K. pneumoniae that were isolated from patients hospitalized at the National Hospital of Tropical Diseases between 2007 and 2011, 332 isolates were recovered after re-cultivation. Of those, 30 isolates with lacking clinical metadata were excluded, leaving the remaining 302 isolates for downstream analysis.” Comment 4: Results I note that ESBL production was determined in Table 2 - please clarify how you determined this in the methods. Response: Thank you very much for your comment. We have added the information into the updated version as below: “A phenotypic confirmatory double-disk test was performed for confirmation of ESBL production using CTX (30 mg) and CAZ (30 mg) disks alone and in combination with CA (10 mg) (Mast Diagnostic a GmbH, Reinfeld, Germany).” Comment 5: Discussion and conclusion I think some discussion about the small numbers of K64 isolates would also be helpful in the limitations of the paper. The second paragraph starts off by suggesting K64 has "been little reported so far," but I think the data from China would argue against this. Response: Thank you for your recommendation. We agree that data from China would argue against our statement in the second paragraph starts off by suggesting K64 has "been little reported so far,". We now have revised the sentence as below: “The capsular type K64 has been reported worldwide, especially from clinical settings in Asia, Europe, and North America and is one of the K types associated with hypervirulent strains, that have shown simultaneous expression of virulence and carbapenem-resistance genes, posing a treatment challenge.” Regarding the small numbers of K64 isolates in our study, we have added into the limitation: “In this study, the relatively small number of K64 isolates provided only limited data about the serotype's convergent virulence and carbapenem resistance. Also, we lack the whole genome sequence data of these K64 isolates for further understanding of the molecular basis of hypervirulence and the phylogenetic positioning of this rare ST within the genomic taxonomy of K. pneumoniae . However, our results led support to the hypothesis that K64 is associated with severe invasive community acquired K. pneumoniae infections, including sepsis and meningitis. In addition, here, only seven capsule types were selected to investigate the diversity of K. pneumoniae isolates. We recognize that this is one of the limitations of our study. Further studies are needed to unravel the mechanisms of virulence of capsule type K64 in K. pneumoniae .” Competing Interests: We do not have any competing interests to disclose Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 17 Jan 2025 Bich Vu Thi Ngoc , Oxford University Clinical Research Unit - Hanoi, Hanoi, Vietnam 17 Jan 2025 Author Response We would like to thank reviewer for your valuable comments. We have addressed all the reviewers’ comments in the revised manuscript, including with additional information, and responded in the point-to-point ... Continue reading We would like to thank reviewer for your valuable comments. We have addressed all the reviewers’ comments in the revised manuscript, including with additional information, and responded in the point-to-point rebuttal below. We hope our revisions are adequate and make our manuscript clear and publishable. Reviewer 1 This paper describes the epidemiology of K64 Klebsiella pneumoniae isolates with a particular focus on K64 from a hospital in Vietnam. Comment 1 : Introduction "...but K64 capsular have rarely been described in healthy carriers." in the introductory paragraph reads a bit unclearly. Response : Thank you very much for your comment. We have now revised the sentence in the updated version as below: “…but carriage of K64 K. pneumoniae in healthy persons has rarely been described.” Comment 2: Adding a bit more about the importance of K64 and the differences between classic and hypervirulent types of Klebsiella spp. (as well as how capsules might play a role in this) would better situate the authors' opening argument as to why they are performing this current study. Response: Thank you very much for your recommendation. We have now included the following sentences in the introduction of the manuscript: K pneumoniae is classified across two main virulence phenotypes, classical (cKp) and hypervirulent (hvKp). Most K. pneumoniae are associated with uncomplicated community acquired infections and nocosomial infections. However, hvKp results in more severe community – acquired infections with manifestations such as pyogenic liver abscess, meningitis, endophthalmitis, and necrotizing fasciitis. The polysaccharide capsule is perhaps the most well-known virulence factor of K. pneumoniae , including for the hvKp phenotype. The capsule surrounding K. pneumoniae cells can be divided into at least 79 capsular types (K1 to K79), among which K1, K2, and K64 are common serotypes of the MDR-hvKp group, which is commonly found in Asia. Comment 3: Methods "302 K. pneumoniae were isolated..." are these all isolates from the hospital during this time period? Response: Thank you very much for your question. The total number of isolates from the hospital during this time was 589 isolates; however, because this was a retrospective study, we performed re-culture, and 332/589 isolates were recovered. Of those, 30 isolates had no associated clinical metadata, and were excluded from the study. We now have clarified this in the manuscript as below: “From a total of 589 K. pneumoniae that were isolated from patients hospitalized at the National Hospital of Tropical Diseases between 2007 and 2011, 332 isolates were recovered after re-cultivation. Of those, 30 isolates with lacking clinical metadata were excluded, leaving the remaining 302 isolates for downstream analysis.” Comment 4: Results I note that ESBL production was determined in Table 2 - please clarify how you determined this in the methods. Response: Thank you very much for your comment. We have added the information into the updated version as below: “A phenotypic confirmatory double-disk test was performed for confirmation of ESBL production using CTX (30 mg) and CAZ (30 mg) disks alone and in combination with CA (10 mg) (Mast Diagnostic a GmbH, Reinfeld, Germany).” Comment 5: Discussion and conclusion I think some discussion about the small numbers of K64 isolates would also be helpful in the limitations of the paper. The second paragraph starts off by suggesting K64 has "been little reported so far," but I think the data from China would argue against this. Response: Thank you for your recommendation. We agree that data from China would argue against our statement in the second paragraph starts off by suggesting K64 has "been little reported so far,". We now have revised the sentence as below: “The capsular type K64 has been reported worldwide, especially from clinical settings in Asia, Europe, and North America and is one of the K types associated with hypervirulent strains, that have shown simultaneous expression of virulence and carbapenem-resistance genes, posing a treatment challenge.” Regarding the small numbers of K64 isolates in our study, we have added into the limitation: “In this study, the relatively small number of K64 isolates provided only limited data about the serotype's convergent virulence and carbapenem resistance. Also, we lack the whole genome sequence data of these K64 isolates for further understanding of the molecular basis of hypervirulence and the phylogenetic positioning of this rare ST within the genomic taxonomy of K. pneumoniae . However, our results led support to the hypothesis that K64 is associated with severe invasive community acquired K. pneumoniae infections, including sepsis and meningitis. In addition, here, only seven capsule types were selected to investigate the diversity of K. pneumoniae isolates. We recognize that this is one of the limitations of our study. Further studies are needed to unravel the mechanisms of virulence of capsule type K64 in K. pneumoniae .” We would like to thank reviewer for your valuable comments. We have addressed all the reviewers’ comments in the revised manuscript, including with additional information, and responded in the point-to-point rebuttal below. We hope our revisions are adequate and make our manuscript clear and publishable. Reviewer 1 This paper describes the epidemiology of K64 Klebsiella pneumoniae isolates with a particular focus on K64 from a hospital in Vietnam. Comment 1 : Introduction "...but K64 capsular have rarely been described in healthy carriers." in the introductory paragraph reads a bit unclearly. Response : Thank you very much for your comment. We have now revised the sentence in the updated version as below: “…but carriage of K64 K. pneumoniae in healthy persons has rarely been described.” Comment 2: Adding a bit more about the importance of K64 and the differences between classic and hypervirulent types of Klebsiella spp. (as well as how capsules might play a role in this) would better situate the authors' opening argument as to why they are performing this current study. Response: Thank you very much for your recommendation. We have now included the following sentences in the introduction of the manuscript: K pneumoniae is classified across two main virulence phenotypes, classical (cKp) and hypervirulent (hvKp). Most K. pneumoniae are associated with uncomplicated community acquired infections and nocosomial infections. However, hvKp results in more severe community – acquired infections with manifestations such as pyogenic liver abscess, meningitis, endophthalmitis, and necrotizing fasciitis. The polysaccharide capsule is perhaps the most well-known virulence factor of K. pneumoniae , including for the hvKp phenotype. The capsule surrounding K. pneumoniae cells can be divided into at least 79 capsular types (K1 to K79), among which K1, K2, and K64 are common serotypes of the MDR-hvKp group, which is commonly found in Asia. Comment 3: Methods "302 K. pneumoniae were isolated..." are these all isolates from the hospital during this time period? Response: Thank you very much for your question. The total number of isolates from the hospital during this time was 589 isolates; however, because this was a retrospective study, we performed re-culture, and 332/589 isolates were recovered. Of those, 30 isolates had no associated clinical metadata, and were excluded from the study. We now have clarified this in the manuscript as below: “From a total of 589 K. pneumoniae that were isolated from patients hospitalized at the National Hospital of Tropical Diseases between 2007 and 2011, 332 isolates were recovered after re-cultivation. Of those, 30 isolates with lacking clinical metadata were excluded, leaving the remaining 302 isolates for downstream analysis.” Comment 4: Results I note that ESBL production was determined in Table 2 - please clarify how you determined this in the methods. Response: Thank you very much for your comment. We have added the information into the updated version as below: “A phenotypic confirmatory double-disk test was performed for confirmation of ESBL production using CTX (30 mg) and CAZ (30 mg) disks alone and in combination with CA (10 mg) (Mast Diagnostic a GmbH, Reinfeld, Germany).” Comment 5: Discussion and conclusion I think some discussion about the small numbers of K64 isolates would also be helpful in the limitations of the paper. The second paragraph starts off by suggesting K64 has "been little reported so far," but I think the data from China would argue against this. Response: Thank you for your recommendation. We agree that data from China would argue against our statement in the second paragraph starts off by suggesting K64 has "been little reported so far,". We now have revised the sentence as below: “The capsular type K64 has been reported worldwide, especially from clinical settings in Asia, Europe, and North America and is one of the K types associated with hypervirulent strains, that have shown simultaneous expression of virulence and carbapenem-resistance genes, posing a treatment challenge.” Regarding the small numbers of K64 isolates in our study, we have added into the limitation: “In this study, the relatively small number of K64 isolates provided only limited data about the serotype's convergent virulence and carbapenem resistance. Also, we lack the whole genome sequence data of these K64 isolates for further understanding of the molecular basis of hypervirulence and the phylogenetic positioning of this rare ST within the genomic taxonomy of K. pneumoniae . However, our results led support to the hypothesis that K64 is associated with severe invasive community acquired K. pneumoniae infections, including sepsis and meningitis. In addition, here, only seven capsule types were selected to investigate the diversity of K. pneumoniae isolates. We recognize that this is one of the limitations of our study. Further studies are needed to unravel the mechanisms of virulence of capsule type K64 in K. pneumoniae .” Competing Interests: We do not have any competing interests to disclose Close Report a concern COMMENT ON THIS REPORT Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 08 Jun 2021 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 3 4 Version 2 (revision) 17 Jan 25 read read read Version 1 08 Jun 21 read read John L. Kiley , Brooke Army Medical Center, San Antonio, USA Frank R. DeLeo , National Institutes of Health, Hamilton, USA Ning Dong , Zhejiang University School of Medicine, Hangzhou, China Neris García-González , Instituto de Biomedicina de Valencia (Ringgold ID: 54426), Valencia, Spain Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2025 García-González N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 09 Aug 2025 | for Version 2 Neris García-González , Instituto de Biomedicina de Valencia (Ringgold ID: 54426), Valencia, Valencian Community, Spain 0 Views copyright © 2025 García-González N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Peer Review for “ Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2]” The manuscript explores the distribution of Klebsiella pneumoniae capsule types, with a focus on K64, among invasive and commensal isolates in Vietnam. While the topic is relevant and the data valuable, I believe the conclusions are overstated given the limited number of K64 isolates. Several aspects of the methodology and analysis require clarification or revision, particularly to address the overstatement of key conclusions. Additionally, the overall writing—especially the methods section—would benefit from careful editing for clarity. Major Comments The conclusion that “Our study confirms that capsule type K64 K. pneumoniae is associated with community-acquired invasive infections in Vietnam” is, in my view, overstated given the data presented. Of the 100 isolates with a successfully determined capsular type, only 11 were K64 (5 from invasive, 2 from commensal samples). This is a very small number, and the application of statistical tests to such low counts does not support a definitive conclusion. Similarly, the claim that K64 is “associated with sepsis and meningitis” is unsupported. While some K64 isolates came from such cases, no analysis was done to test specific disease associations. This should be rephrased more cautiously (e.g., “were observed in”). The statement that “K64-ST799 might have acquired a mobile element carrying a carbapenemase gene” is speculative and not backed by molecular data. Without sequencing or resistance gene analysis, this claim should be softened. The authors tested for only seven capsule types (K1, K2, K5, K20, K54, K57, K64). It’s unclear why these were chosen—are they the most common in Vietnam, or just associated with hvKp globally? This should be clarified, especially since over half of the isolates were untypeable. Without knowing whether additional relevant types were missed, it is difficult to interpret the significance of the K64 frequency. The invasive isolates were collected between 2007–2011, while the commensal isolates were collected in 2012. The invasive and commensal isolates were collected in different time periods (2007–2011 vs. 2012), which could introduce temporal bias. This limitation should be acknowledged explicitly. The manuscript requires substantial revision for clarity. Several sentences are difficult to parse, and the structure of some sections hinders comprehension. For example: The methodology does not clearly explain how the 589 K. pneumoniae isolates were selected. Were these all from invasive infections? If so, and only 49.2% were typeable, a large proportion of relevant invasive capsule types may have been missed. Alternatively, if this set included both invasive and commensal isolates, it would improve the comparison by providing community data from the same time period. This should be clearly stated and clarified in the manuscript. The distinction between the two datasets (invasive and commensal) is clear in the abstract but not well explained in the main text. I suggest rephrasing to something similar to: “To compare invasive with commensal isolates, we included commensal isolates from a previous study. These were throat swabs from healthy volunteers in rural and urban Hanoi in 2012. …” The statement: “To ensure that the isolates were from community-acquired infections, we used a time difference of ≥48 hours…” is confusing. Community-acquired infections are typically defined as those occurring within 48 hours of hospital admission. This should be reworded for clarity. Minor Comments Define MDR (multidrug-resistant) on first mention. In Tables 1 and 2, “Overall” column should also have (n, %) Correct spelling of “nocosomial” to “nosocomial.” Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Partly Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Partly Are all the source data underlying the results available to ensure full reproducibility? No source data required Are the conclusions drawn adequately supported by the results? Partly Competing Interests No competing interests were disclosed. Reviewer Expertise microbial genomics I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (0) García-González N. Peer Review Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r393103) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-393103 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2025 Dong N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 06 Jun 2025 | for Version 2 Ning Dong , Zhejiang University School of Medicine, Hangzhou, China 0 Views copyright © 2025 Dong N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Not Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions In this study on Klebsiella pneumoniae , the authors analyzed 203 clinical isolates and found that capsular K64 was significantly enriched in invasive infections, mainly associated with sepsis and meningitis, and some K64 strains (such as ST799) were multidrug resistant. This study suggests that K64 is an important pathogen of community-acquired invasive infections in Vietnam. I suggest the following directions for further improvement of the study: The theoretical basis for capsule type selection was supplemented, and the latest literature (such as studies on the global prevalence of K64 after 2023) was cited to complete the discussion section. The sample size was small and underrepresented. The sample size of K64 strains was only 7 strains (5 invasive strains and 2 commensal strains), which was too small to support the conclusion that K64 was significantly enriched in invasive infections, which may lead to limited reliability of statistical results. Second, the commensal strains lack sample coverage from multiple regions and time points to fully reflect the epidemiological characteristics of community-acquired infections in Vietnam. The results "K64 with varying sequence types were predominantly seen among invasive K. pneumoniae (8 vs. 3)" was inconsistent with the table data in the text (5 invasive strains, 2 commensal strains). The whole genome sequencing data was supplemented to analyze the virulence genes (such as rmpA and magA ) and drug resistance genes (such as KPC and NDM ) of K64 strain, and to clarify its pathogenic mechanism at the molecular level. There is a logical jump between the conclusion and the data. The title and conclusion use the word "overrepresented", which is misleading. Because the proportion of K64 in invasive strains was only 5.4% (5/93), which was much lower than that of K1 (24.7%) and K2 (22.6%). Second, it was mentioned that K64 was associated with carbapenem resistance (such as the ST799 strain). However, the finding of only one drug-resistant strain cannot support the inference that the K64 strain is generally resistant to carbapenem, and more data are needed to verify it. Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Partly Competing Interests No competing interests were disclosed. Reviewer Expertise Epidemiology of infectious diseases I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above. reply Respond to this report Responses (0) Dong N. Peer Review Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r383866) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-383866 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2025 DeLeo F. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. 28 Jan 2025 | for Version 2 Frank R. DeLeo , Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA 0 Views copyright © 2025 DeLeo F. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Revised version is appropriate. Competing Interests No competing interests were disclosed. Reviewer Expertise Bacterial pathogenesis and host defense. Primary focus on Staphylococcus aureus, Klebsiella pneumoniae, and human neutrophil biology. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) DeLeo FR. Peer Review Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.176630.r360165) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/10-454/v2#referee-response-360165 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 DeLeo F. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. 28 Jun 2024 | for Version 1 Frank R. DeLeo , Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA 0 Views copyright © 2024 DeLeo F. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. format_quote Cite this report speaker_notes Responses (0) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Ngoc et al. report capsule type and multilocus sequence type of Klebsiella pneumoniae clinical isolates from patients hospitalized at National Hospital for Tropical Diseases in Hanoi from 2007 to 2011. The authors compared these isolates to commensal isolates obtained by throat swab from healthy volunteers in 2012. The study is interesting and adds to our understanding of the distribution of the K. pneumoniae capsule types associated with human infections. I have a few comments for the authors to consider. Please verify numbers of isolates in Table 1 compared with what is stated in the text. By my count, there are 110 commensal isolates (correct in the text) and 94 (stated as 93 in the text) invasive isolates. These numbers are concordant with the sum of the numbers in the Overall column, which total 204 isolates (the text indicates 203). Please verify for accuracy. It would be optimal to provide text in the Table 1 legend that states what the p-value refers to from a comparison standpoint, and indicate the test used here as well. I recommend providing the rationale for selecting the seven capsule types used to screen isolates in this study. Why were these seven capsule types chosen among others? A conclusion of the study is that “capsule type K64 is overrepresented among invasive strains”. In reality there are only seven K64 isolates out of 204 total isolates and only five of these were from invasive disease. This is 5.4% of the total number of invasive isolates and much less than either K1 or K2. In addition, the Conclusion text on the title page states that K64 K. pneumoniae is associated with community-acquired invasive infections in Vietnam.” Please provide the criteria in the Methods section that were used to determine whether an infection is a bona fide community-acquired infection. It would be fair to state that K64 contributes to invasive disease and is among the top three capsule types tested that are associated with invasive infections. However, the term “overrepresented among invasive strains” might best be restated as “there were significantly more capsule type K64 isolates recovered from patients with invasive infections compared to healthy individuals with commensal isolates” or something along those lines. Minor points. Introduction: “A genomic analysis of diversity and population structure of 288 human and animal K. pneumoniae isolates from six countries, spanning four continents, has shown that K64 mostly found in Vietnam (n = 3) and Singapore (n = 1), was among the important capsule types associated with community acquired pneumonia.” is not easy to read. Consider revising to: “A genomic analysis of diversity and population structure of 288 human and animal K. pneumoniae isolates from six countries, spanning four continents, has shown that K64 was among the important capsule types associated with community acquired pneumonia in Vietnam (n = 3) and Singapore (n = 1).” Introduction, penultimate sentence: change K64 capsular to K64 capsule types Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Partly If applicable, is the statistical analysis and its interpretation appropriate? I cannot comment. A qualified statistician is required. Are all the source data underlying the results available to ensure full reproducibility? Partly Are the conclusions drawn adequately supported by the results? Partly Competing Interests No competing interests were disclosed. Reviewer Expertise Bacterial pathogenesis and host defense. Primary focus on Staphylococcus aureus, Klebsiella pneumoniae, and human neutrophil biology. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (0) DeLeo FR. Peer Review Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.56121.r287539) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/10-454/v1#referee-response-287539 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2021 Kiley J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 12 Oct 2021 | for Version 1 John L. Kiley , Brooke Army Medical Center, San Antonio, TX, USA 0 Views copyright © 2021 Kiley J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions This paper describes the epidemiology of K64 Klebsiella pneumoniae isolates with a particular focus on K64 from a hospital in Vietnam. Introduction "...but K64 capsular have rarely been described in healthy carriers." in the introductory paragraph reads a bit unclearly. Adding a bit more about the importance of K64 and the differences between classic and hypervirulent types of Klebsiella spp. (as well as how capsules might play a role in this) would better situate the authors' opening argument as to why they are performing this current study. Methods "302 K. pneumoniae were isolated..." are these all isolates from the hospital during this time period? Results I note that ESBL production was determined in Table 2 - please clarify how you determined this in the methods. Discussion and conclusion I think some discussion about the small numbers of K64 isolates would also be helpful in the limitations of the paper. The second paragraph starts off by suggesting K64 has "been little reported so far," but I think the data from China would argue against this. Zhang et al ., 2020 reported Chinese epidemiological data on K64 1 . Walker et al ., 2020 for general discussion of hypervirulence and association with capsular type 2 . Catalán-Nájera et al ., 2017 for hypermucoviscious, hypervirulent differences/discussion 3 . Great paper overall! Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes References 1. Zhang Y, Jin L, Ouyang P, Wang Q, et al.: Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. Journal of Antimicrobial Chemotherapy . 2020; 75 (2): 327-336 Publisher Full Text 2. Walker KA, Miller VL: The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae. Curr Opin Microbiol . 54 : 95-102 PubMed Abstract | Publisher Full Text 3. Catalán-Nájera J, Garza-Ramos U, Barrios-Camacho H: Hypervirulence and hypermucoviscosity: Two different but complementaryKlebsiella spp. phenotypes?. Virulence . 2017; 8 (7): 1111-1123 Publisher Full Text Competing Interests No competing interests were disclosed. Reviewer Expertise Multi drug resistant Gram-negative infections I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (1) Author Response 17 Jan 2025 Bich Vu Thi Ngoc, Oxford University Clinical Research Unit - Hanoi, Hanoi, Vietnam We would like to thank reviewer for your valuable comments. We have addressed all the reviewers’ comments in the revised manuscript, including with additional information, and responded in the point-to-point rebuttal below. We hope our revisions are adequate and make our manuscript clear and publishable. Reviewer 1 This paper describes the epidemiology of K64 Klebsiella pneumoniae isolates with a particular focus on K64 from a hospital in Vietnam. Comment 1 : Introduction "...but K64 capsular have rarely been described in healthy carriers." in the introductory paragraph reads a bit unclearly. Response : Thank you very much for your comment. We have now revised the sentence in the updated version as below: “…but carriage of K64 K. pneumoniae in healthy persons has rarely been described.” Comment 2: Adding a bit more about the importance of K64 and the differences between classic and hypervirulent types of Klebsiella spp. (as well as how capsules might play a role in this) would better situate the authors' opening argument as to why they are performing this current study. Response: Thank you very much for your recommendation. We have now included the following sentences in the introduction of the manuscript: K pneumoniae is classified across two main virulence phenotypes, classical (cKp) and hypervirulent (hvKp). Most K. pneumoniae are associated with uncomplicated community acquired infections and nocosomial infections. However, hvKp results in more severe community – acquired infections with manifestations such as pyogenic liver abscess, meningitis, endophthalmitis, and necrotizing fasciitis. The polysaccharide capsule is perhaps the most well-known virulence factor of K. pneumoniae , including for the hvKp phenotype. The capsule surrounding K. pneumoniae cells can be divided into at least 79 capsular types (K1 to K79), among which K1, K2, and K64 are common serotypes of the MDR-hvKp group, which is commonly found in Asia. Comment 3: Methods "302 K. pneumoniae were isolated..." are these all isolates from the hospital during this time period? Response: Thank you very much for your question. The total number of isolates from the hospital during this time was 589 isolates; however, because this was a retrospective study, we performed re-culture, and 332/589 isolates were recovered. Of those, 30 isolates had no associated clinical metadata, and were excluded from the study. We now have clarified this in the manuscript as below: “From a total of 589 K. pneumoniae that were isolated from patients hospitalized at the National Hospital of Tropical Diseases between 2007 and 2011, 332 isolates were recovered after re-cultivation. Of those, 30 isolates with lacking clinical metadata were excluded, leaving the remaining 302 isolates for downstream analysis.” Comment 4: Results I note that ESBL production was determined in Table 2 - please clarify how you determined this in the methods. Response: Thank you very much for your comment. We have added the information into the updated version as below: “A phenotypic confirmatory double-disk test was performed for confirmation of ESBL production using CTX (30 mg) and CAZ (30 mg) disks alone and in combination with CA (10 mg) (Mast Diagnostic a GmbH, Reinfeld, Germany).” Comment 5: Discussion and conclusion I think some discussion about the small numbers of K64 isolates would also be helpful in the limitations of the paper. The second paragraph starts off by suggesting K64 has "been little reported so far," but I think the data from China would argue against this. Response: Thank you for your recommendation. We agree that data from China would argue against our statement in the second paragraph starts off by suggesting K64 has "been little reported so far,". We now have revised the sentence as below: “The capsular type K64 has been reported worldwide, especially from clinical settings in Asia, Europe, and North America and is one of the K types associated with hypervirulent strains, that have shown simultaneous expression of virulence and carbapenem-resistance genes, posing a treatment challenge.” Regarding the small numbers of K64 isolates in our study, we have added into the limitation: “In this study, the relatively small number of K64 isolates provided only limited data about the serotype's convergent virulence and carbapenem resistance. Also, we lack the whole genome sequence data of these K64 isolates for further understanding of the molecular basis of hypervirulence and the phylogenetic positioning of this rare ST within the genomic taxonomy of K. pneumoniae . However, our results led support to the hypothesis that K64 is associated with severe invasive community acquired K. pneumoniae infections, including sepsis and meningitis. In addition, here, only seven capsule types were selected to investigate the diversity of K. pneumoniae isolates. We recognize that this is one of the limitations of our study. Further studies are needed to unravel the mechanisms of virulence of capsule type K64 in K. pneumoniae .” View more View less Competing Interests We do not have any competing interests to disclose reply Respond Report a concern Kiley JL. Peer Review Report For: Klebsiella pneumoniae with capsule type K64 is overrepresented among invasive disease in Vietnam [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved] . F1000Research 2025, 10 :454 ( https://doi.org/10.5256/f1000research.56121.r93803) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/10-454/v1#referee-response-93803 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Klebsiella pneumoniae with capsule type K64...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/10-454/v2" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/10-454/v2&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/10-454/v2" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Vu Thi Ngoc B et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/10-454/v2/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/10-454", templates : { twitter : "Klebsiella pneumoniae with capsule type K64 is overrepresented.... Vu Thi Ngoc B et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/10-454/v2" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/52799/176630") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "176630"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "279044": 0, "279045": 0, "279046": 0, "279047": 0, "382209": 0, "382208": 0, "382211": 0, "92679": 0, "382210": 0, "92681": 0, "119561": 0, "92680": 0, "279048": 0, "93455": 0, "93454": 0, "169490": 0, "169488": 0, "169489": 0, "120345": 0, "255531": 0, "255530": 0, "255529": 0, "128042": 0, "255534": 0, "255533": 0, "255532": 0, "287540": 0, "287541": 0, "287542": 0, "287543": 0, "287539": 20, "287544": 0, "287545": 0, "287546": 0, "100675": 0, "100674": 0, "100676": 0, "120913": 0, "120915": 0, "120914": 0, "120916": 0, "102487": 0, "123993": 0, "123992": 0, "123995": 0, "123994": 0, "93803": 37, "383861": 0, "383860": 0, "383863": 0, "383862": 0, "383859": 0, "383868": 0, "383865": 0, "115325": 0, "383864": 0, "87932": 0, "115324": 0, "383867": 0, "383866": 6, "371845": 0, "115329": 0, "115328": 0, "371847": 0, "371846": 0, "115330": 0, "393101": 0, "371853": 0, "393100": 0, "371852": 0, "393103": 6, "95115": 0, "393102": 0, "393097": 0, "371849": 0, "95117": 0, "393096": 0, "371848": 0, "95116": 0, "393099": 0, "371851": 0, "393098": 0, "371850": 0, "95118": 0, "393105": 0, "393104": 0, "371858": 0, "94105": 0, "375205": 0, "87969": 0, "375204": 0, "375207": 0, "375206": 0, "375201": 0, "375203": 0, "375202": 0, "377773": 0, "377775": 0, "377774": 0, "375209": 0, "375208": 0, "375210": 0, "377781": 0, "377780": 0, "377782": 0, "377777": 0, "377776": 0, "377779": 0, "377778": 0, "98760": 0, "98763": 0, "98769": 0, "87505": 0, "98768": 0, "98774": 0, "92383": 0, "92382": 0, "273883": 0, "360165": 9, "386021": 0, "360164": 0, "386020": 0, "92384": 0, "386023": 0, "386022": 0, "386017": 0, "89573": 0, "386016": 0, "386019": 0, "89575": 0, "386018": 0, "89574": 0, "386029": 0, "89577": 0, "89576": 0, "89578": 0, "386025": 0, "386024": 0, "380149": 0, "380151": 0, "380150": 0, "87031": 0, "382205": 0, "380157": 0, "87033": 0, "382204": 0, "380156": 0, "87032": 0, "382207": 0, "87035": 0, "382206": 0, "380158": 0, "87034": 0, "380153": 0, "380152": 0, "382203": 0, "380155": 0, "382202": 0, "380154": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "47c802eb-5cb7-4261-987f-02da636df2ba"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });